By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Vermillion today said that Nasdaq has approved its application to get relisted on the exchange's Global Market.
As a result, the company's common stock began trading on the Nasdaq under ticker symbol "VRML" this morning.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.